microdosing glp-1 what is it Drugs: To Know Thinking About Microdosing GLP-1? 5
Description
For the drinks trade, the shift may test established alcohol led revenue models
MEET THE EXPERT Dr Paula Diab is a diabetologist at Atrium Lifestyle Centre and is an extra-ordinary lecturer, Dept of Family Medicine, University of Pretoria
There are hints it might be
The results have prompted a clinical trial to determine whether the association reflects a true protective effect
The efficacy of GLP-1 agonists was notable for various conditions, including psoriasis, hidradenitis suppurativa, acanthosis nigricans, and Hailey-Hailey disease
